NCT05808790View on ClinicalTrials.gov

Colorectal Pulmonary Metastases: Pulmonary Metastasectomy Versus Stereotactic Ablative Radiotherapy

NANot yet recruitingINTERVENTIONAL
Enrollment

394

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2030

Conditions
Lung MetastasesColorectal Cancer Metastatic
Interventions
PROCEDURE

Minimally invasive pulmonary metastasectomy

Surgical margin is equal to tumor size, if possible The goal is a parenchymal-sparing resection

RADIATION

Stereotactic ablative radiotherapy

Depending on tumor location, 54 Gy in 3 fractions, 55 Gy in 5 fractions, 60 Gy in 8 fractions.

Trial Locations (1)

1081 HZ

Amsterdam University Medical Center (AUMC), Amsterdam

All Listed Sponsors
collaborator

Dutch Cancer Society

OTHER

lead

Amsterdam UMC, location VUmc

OTHER

NCT05808790 - Colorectal Pulmonary Metastases: Pulmonary Metastasectomy Versus Stereotactic Ablative Radiotherapy | Biotech Hunter | Biotech Hunter